StockData
PAVmed Inc. logo

PAVmed Inc. (PAVM) stock

PAVMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$1.51−0.24 (-13.71%)

Close on Nov 17, 2026Market cap $12.07MP/E –Yield –

PAVmed r&d expenses

Research and development expenses are spending on new products and technology.

PAVmed's R&D Expenses for the twelve months ending Jun 30, 2026 was $6.37M, up 62.3% year over year. For fiscal 2025 it was $4.49M, down 24.3% from the year before. Over ten years it grew 24.8% a year on average. The highest annual figure on record is $25.34M in fiscal 2022.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$4.49M-24.3%
FY2024Dec 31, 2024$5.93M-58.4%
FY2023Dec 31, 2023$14.28M-43.7%
FY2022Dec 31, 2022$25.34M+27.7%
FY2021Dec 31, 2021$19.85M+81.0%
FY2020Dec 31, 2020$10.96M+65.4%
FY2019Dec 31, 2019$6.63M+55.9%
FY2018Dec 31, 2018$4.25M+62.2%
FY2017Dec 31, 2017$2.62M+52.5%
FY2016Dec 31, 2016$1.72M+251.4%
FY2015Dec 31, 2015$489.33K–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$2.07M+161.6%
Q1 FY2026Mar 31, 2026$1.39M+76.4%
Q4 FY2025Dec 31, 2025$1.83M+126.5%
Q3 FY2025Sep 30, 2025$1.09M-29.4%
Q2 FY2025Jun 30, 2025$790.00K-51.9%
Q1 FY2025Mar 31, 2025$787.00K-59.5%
Q4 FY2024Dec 31, 2024$807.00K-77.6%
Q3 FY2024Sep 30, 2024$1.54M-51.2%
Q2 FY2024Jun 30, 2024$1.64M-52.7%
Q1 FY2024Mar 31, 2024$1.94M-52.1%
Q4 FY2023Dec 31, 2023$3.60M-46.1%
Q3 FY2023Sep 30, 2023$3.16M-49.0%
Q2 FY2023Jun 30, 2023$3.47M-48.5%
Q1 FY2023Mar 31, 2023$4.05M-31.7%
Q4 FY2022Dec 31, 2022$6.67M-4.2%
Q3 FY2022Sep 30, 2022$6.20M+16.9%
Q2 FY2022Jun 30, 2022$6.74M+58.3%
Q1 FY2022Mar 31, 2022$5.93M+78.9%
Q4 FY2021Dec 31, 2021$6.97M+91.4%
Q3 FY2021Sep 30, 2021$5.31M+102.6%
Q2 FY2021Jun 30, 2021$4.26M+99.6%
Q1 FY2021Mar 31, 2021$3.32M+26.1%
Q4 FY2020Dec 31, 2020$3.64M+61.6%
Q3 FY2020Sep 30, 2020$2.62M+72.3%
Q2 FY2020Jun 30, 2020$2.13M+51.8%
Q1 FY2020Mar 31, 2020$2.63M+81.1%
Q4 FY2019Dec 31, 2019$2.25M+64.8%
Q3 FY2019Sep 30, 2019$1.52M+29.6%
Q2 FY2019Jun 30, 2019$1.41M+22.3%
Q1 FY2019Mar 31, 2019$1.45M+157.6%
Q4 FY2018Dec 31, 2018$1.37M+145.1%
Q3 FY2018Sep 30, 2018$1.17M+66.4%
Q2 FY2018Jun 30, 2018$1.15M+63.7%
Q1 FY2018Mar 31, 2018$563.22K-14.2%
Q4 FY2017Dec 31, 2017$558.21K-8.0%
Q3 FY2017Sep 30, 2017$704.87K+21.8%
Q2 FY2017Jun 30, 2017$701.74K–
Q1 FY2017Mar 31, 2017$656.71K–
Q4 FY2016Dec 31, 2016$606.97K–
Q3 FY2016Sep 30, 2016$578.47K–

More PAVmed figures

See a number that looks wrong?